Search company, investor...
Search

Founded Year

2018

Stage

Series B | Alive

Total Raised

$174.59M

Last Raised

$100M | 1 yr ago

About Singleron

Singleron is a developer of gene sequencing technology, focusing on massive and single-cell multi-omics analysis for drug development, scientific research, and genomics industries. The company develops a series of molecular diagnostic products and automation devices that can meet clinical applications.

Singleron Headquarters Location

Jiyin Building, 10/F 211 Pubin Rd, Jiangbei New District

Nanjing, Jiangsu,

China

+86 025-58165529

ESPs containing Singleron

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Biopharma Tech

These companies provide laboratory equipment and software to sequence, observe, and analyze individual cells. Solutions in this space enable pharma companies to develop therapies based on rare cellular genetics and phenotypes.

Singleron named as Leader among 15 other companies, including Mission Bio, Celsius Therapeutics, and HiFiBiO Therapeutics.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Singleron's Products & Differentiation

See Singleron's products and how their products differentiate from alternatives and competitors

  • Singleron Matrix™ Single Cell Processing System

    Singleron Matrix™ automated single cell processing system can be used as an intergrated part for the preparation of single-cell sequencing libraries. The instrument can dispense the single cells in suspension into the proprietary SCOPE™ microwell chip, and automatically complete the cell separation, cell lysis, and mRNA capture steps within 30 minutes. The instrument greatly simplifies the operation process of single-cell sequencing library construction, reduces manual steps to improve the stability and reproducibility of the results. Singleron Matrix™ can be operated in parallel with one or two SCOPE-chips. 500 to 60,000 single cells can be captured per run.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Singleron

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Singleron in 2 CB Insights research briefs, most recently on Feb 15, 2022.

Expert Collections containing Singleron

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Singleron is included in 6 Expert Collections, including Digital Health.

D

Digital Health

469 items

M

Medical Devices

8,490 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

H

Health IT

7,901 items

D

Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

Singleron Patents

Singleron has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/29/2021

Application

Application Date

7/29/2021

Grant Date

Title

Related Topics

Status

Application

Latest Singleron News

Singleron supports Project Maleth’s second mission MALETH II by analyzing biological samples sent to space

Jul 15, 2022

Singapore, SINGAPORE COLOGNE, Germany, July 14, 2022 (GLOBE NEWSWIRE) -- Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta. The second mission under the Maleth Program, or Maleth II, was launched on the July 15th, 2022. "Maleth II boarded a SpaceX Dragon Spacecraft for the launch as part of Commercial Re-supply mission 25 (CRS25) destined for the International Space Station and will stay in orbit for around 60 days", said Prof. Borg. Singleron Biotechnologies , a single cell multi-omics company based in Cologne, Germany, proudly supports this exciting project along with the Ministry for Foreign and European Affairs, the Ministry for Education of Malta, and MeDirect – Malta’s first digital Bank. The mission is being facilitated by the Research, Innovation, Development Trust (RIDT) that will be supporting University of Malta students. The Maleth II biocube will once again be remotely controlled from Malta, by Arkafort Ltd. in collaboration with Prof. Borg and can have real-time telemetry data on the running experiment on board the space station. "Alongside the human skin tissue samples to study microbiome involved in diabetic foot ulcers, is also a yeast sample that forms part of an ongoing mini-project supported by Singleron Biotechnologies to detect at a single cell level all the genetic changes inside the yeast cells when exposed to low earth orbit conditions", explained Prof. Borg. Singleron is proud to be a partner in this exciting research project from Europe and believes that single cell analysis can be a powerful tool to understand the impact of space trips on biological organisms ranging from yeast to human. About Singleron Founded in 2018, Singleron develops and commercializes single-cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single-cell analysis. The company currently has offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in over 1,600 laboratories in hospitals, research institutes, and pharmaceutical companies. Media Contact

Singleron Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Singleron Rank

  • When was Singleron founded?

    Singleron was founded in 2018.

  • Where is Singleron's headquarters?

    Singleron's headquarters is located at Jiyin Building, 10/F, Nanjing.

  • What is Singleron's latest funding round?

    Singleron's latest funding round is Series B.

  • How much did Singleron raise?

    Singleron raised a total of $174.59M.

  • Who are the investors of Singleron?

    Investors of Singleron include Lilly Asia Ventures, CDH Investments, Sherpa Venture Capital, SoftBank China Venture Capital, CDG Capital and 12 more.

  • Who are Singleron's competitors?

    Competitors of Singleron include Analytical BioSciences and 1 more.

  • What products does Singleron offer?

    Singleron's products include Singleron Matrix™ Single Cell Processing System and 4 more.

  • Who are Singleron's customers?

    Customers of Singleron include Nantong University Medical School and University Hospital Cologne .

You May Also Like

BioTuring Logo
BioTuring

BioTuring developed hera, a program for RNA-Seq data analysis, including read alignment, quantifying abundances of transcripts, and detecting gene fusions.

Partek Logo
Partek

Partek provides analysis software and services for life sciences research and specializes in innovative solutions for integrated genomics, big data, and mobile cloud computing.

S
SeekGene

SeekGene specializes in single-cell sequencing and TCR-pMHC pairing technologies in understanding immune responses in the single-cell resolution to help screen, treat and monitor diseases.

Analytical BioSciences Logo
Analytical BioSciences

Analytical BioSciences focuses on the research of single-cell genome research for human medicine, especially the establishment of single-cell big data platform, intelligent analysis process, and in-depth interpretation program.

Singular Genomics Logo
Singular Genomics

Singular Genomics (NASDAQ: OMIC) develops a third-gen DNA sequencing system. The sequencing by synthesis system is based on technology licensed out of Jingyue Ju's lab at Columbia.

10X Genomics Logo
10X Genomics

10X Genomics is a life science technology company building products to interrogate, understand and master biology. Its integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.